{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:46:21Z","timestamp":1784126781015,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03264-8","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:19:47Z","timestamp":1761862787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preparation and Optimization of Pramipexole Hydrochloride Solid Dispersions to Improve Drug Release and Bioavailability"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0977-4498","authenticated-orcid":false,"given":"Yuanyuan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4742-6975","authenticated-orcid":false,"given":"Zhenkun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6278-0379","authenticated-orcid":false,"given":"Guodong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8957-9949","authenticated-orcid":false,"given":"Na","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-355X","authenticated-orcid":false,"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8932-5128","authenticated-orcid":false,"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3206-4259","authenticated-orcid":false,"given":"Yuheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3076-9840","authenticated-orcid":false,"given":"Ruijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"5","key":"3264_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","volume":"127","author":"JD Elsworth","year":"2020","unstructured":"Elsworth JD. Parkinson\u2019s disease treatment: past, present, and future. J Neural Transm. 2020;127(5):785\u201391. https:\/\/doi.org\/10.1007\/s00702-020-02167-1.","journal-title":"J Neural Transm"},{"issue":"7","key":"3264_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","volume":"20","author":"N Vijiaratnam","year":"2021","unstructured":"Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson\u2019s disease. Lancet Neurol. 2021;20(7):559\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(21)00061-2.","journal-title":"Lancet Neurol"},{"issue":"17","key":"3264_CR3","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","volume":"11","author":"SM Wilson","year":"2020","unstructured":"Wilson SM, Wurst MG, Whatley MF, Daniels RN. Classics in chemical neuroscience: pramipexole. ACS Chem Neurosci. 2020;11(17):2506\u201312. https:\/\/doi.org\/10.1021\/acschemneuro.0c00332.","journal-title":"ACS Chem Neurosci"},{"key":"3264_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091453","author":"H Windolf","year":"2021","unstructured":"Windolf H, Chamberlain R, Quodbach J. Predicting drug release from 3D printed oral medicines based on the surface area to volume ratio of tablet geometry. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13091453.","journal-title":"Pharmaceutics"},{"key":"3264_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8518929","volume":"2017","author":"JY Yun","year":"2017","unstructured":"Yun JY, Kim YE, Yang HJ, Kim HJ, Jeon B. Twice-daily versus once-daily pramipexole extended release dosage regimens in Parkinson\u2019s disease. Parkinsons Dis. 2017;2017:8518929. https:\/\/doi.org\/10.1155\/2017\/8518929.","journal-title":"Parkinsons Dis"},{"issue":"18","key":"3264_CR6","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s40265-014-0322-5","volume":"74","author":"JE Frampton","year":"2014","unstructured":"Frampton JE. Pramipexole extended-release: a review of its use in patients with Parkinson\u2019s disease. Drugs. 2014;74(18):2175\u201390. https:\/\/doi.org\/10.1007\/s40265-014-0322-5.","journal-title":"Drugs"},{"issue":"1","key":"3264_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40199-022-00440-0","volume":"30","author":"K Patel","year":"2022","unstructured":"Patel K, Shah S, Patel J. Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: a comprehensive review. DARU J Pharm Sci. 2022;30(1):165\u201389. https:\/\/doi.org\/10.1007\/s40199-022-00440-0.","journal-title":"DARU J Pharm Sci"},{"issue":"8","key":"3264_CR8","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01849-z","volume":"21","author":"AR Nair","year":"2020","unstructured":"Nair AR, Lakshman YD, Anand VSK, Sree KSN, Bhat K, Dengale SJ. Overview of extensively employed polymeric carriers in solid dispersion technology. AAPS PharmSciTech. 2020;21(8):309. https:\/\/doi.org\/10.1208\/s12249-020-01849-z.","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"3264_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/17425247.2020.1788541","volume":"17","author":"S Wang","year":"2020","unstructured":"Wang S, Liu R, Fu Y, Kao WJ. Release mechanisms and applications of drug delivery systems for extended-release. Expert Opin Drug Deliv. 2020;17(9):1289\u2013304. https:\/\/doi.org\/10.1080\/17425247.2020.1788541.","journal-title":"Expert Opin Drug Deliv"},{"key":"3264_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejps.2017.01.009","volume":"100","author":"S Zhang","year":"2017","unstructured":"Zhang S, Meng X, Wang Z, Fan A, Wang G, Zhao Y, et al. Engineering hot-melt extruded solid dispersion for controlled release of hydrophilic drugs. Eur J Pharm Sci. 2017;100:109\u201315. https:\/\/doi.org\/10.1016\/j.ejps.2017.01.009.","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"3264_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121255","volume":"14","author":"JH Lee","year":"2021","unstructured":"Lee JH, Park C, Weon KY, Kang CY, Lee BJ, Park JB. Improved bioavailability of poorly water-soluble drug by targeting increased absorption through solubility enhancement and precipitation inhibition. Pharmaceuticals (Basel). 2021;14(12):1255. https:\/\/doi.org\/10.3390\/ph14121255.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"3264_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1872211314666200117094406","volume":"14","author":"R Kaushik","year":"2020","unstructured":"Kaushik R, Budhwar V, Kaushik D. An overview on recent patents and technologies on solid dispersion. Recent Pat Drug Deliv Formul. 2020;14(1):63\u201374. https:\/\/doi.org\/10.2174\/1872211314666200117094406.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"3264_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124651","volume":"664","author":"AZM Badruddoza","year":"2024","unstructured":"Badruddoza AZM, Moseson DE, Lee HG, Esteghamatian A, Thipsay P. Role of rheology in formulation and process design of hot melt extruded amorphous solid dispersions. Int J Pharm. 2024;664:124651. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124651.","journal-title":"Int J Pharm"},{"key":"3264_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030344","author":"JH Lee","year":"2021","unstructured":"Lee JH, Jeong HS, Jeong JW, Koo TS, Kim DK, Cho YH, et al. The development and optimization of hot-melt extruded amorphous solid dispersions containing Rivaroxaban in combination with polymers. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13030344.","journal-title":"Pharmaceutics"},{"key":"3264_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123490","volume":"646","author":"J Han","year":"2023","unstructured":"Han J, Tang M, Yang Y, Sun W, Yue Z, Zhang Y, et al. Amorphous solid dispersions: stability mechanism, design strategy and key production technique of hot melt extrusion. Int J Pharm. 2023;646:123490. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123490.","journal-title":"Int J Pharm"},{"issue":"7","key":"3264_CR16","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01813-x","volume":"21","author":"U Nandi","year":"2020","unstructured":"Nandi U, Mithu MSH, Hurt AP, Trivedi V, Douroumis D. Drug-smectite clay amorphous solid dispersions processed by hot melt extrusion. AAPS PharmSciTech. 2020;21(7):276. https:\/\/doi.org\/10.1208\/s12249-020-01813-x.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"3264_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020213","volume":"13","author":"A Alshetaili","year":"2021","unstructured":"Alshetaili A, Almutairy BK, Alshehri SM, Repka MA. Development and characterization of sustained-released Donepezil hydrochloride solid dispersions using hot melt extrusion technology. Pharmaceutics. 2021;13(2):213. https:\/\/doi.org\/10.3390\/pharmaceutics13020213.","journal-title":"Pharmaceutics"},{"key":"3264_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020737","author":"W Fan","year":"2023","unstructured":"Fan W, Wu J, Gao M, Zhang X, Zhu W. Preparation of solid dispersion of Polygonum cuspidatum extract by hot melt extrusion to enhance oral bioavailability of Resveratrol. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28020737.","journal-title":"Molecules"},{"issue":"6","key":"3264_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2622-7","volume":"36","author":"H Yamashita","year":"2019","unstructured":"Yamashita H, Sun CC. Expedited tablet formulation development of a highly soluble Carbamazepine cocrystal enabled by precipitation inhibition in diffusion layer. Pharm Res. 2019;36(6):90. https:\/\/doi.org\/10.1007\/s11095-019-2622-7.","journal-title":"Pharm Res"},{"key":"3264_CR20","doi-asserted-by":"publisher","unstructured":"Li J, Sun L, Liu Y, Yao H, Jiang S, YunzhuPu, et al. To reduce premature drug release while ensuring burst intracellular drug release of solid lipid nanoparticle-based drug delivery system with clathrin modification. Nanomedicine. 2019;15(1):108\u201318. https:\/\/doi.org\/10.1016\/j.nano.2018.05.014.","DOI":"10.1016\/j.nano.2018.05.014"},{"issue":"6","key":"3264_CR21","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1435-7","volume":"20","author":"S Yi","year":"2019","unstructured":"Yi S, Wang J, Lu Y, Ma R, Gao Q, Liu S, et al. Novel hot melt extruded matrices of hydroxypropyl cellulose and amorphous felodipine-plasticized hydroxypropyl methylcellulose as controlled release systems. AAPS PharmSciTech. 2019;20(6):219. https:\/\/doi.org\/10.1208\/s12249-019-1435-7.","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"3264_CR22","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1021\/acs.biomac.2c00730","volume":"23","author":"T Kanamaru","year":"2022","unstructured":"Kanamaru T, Sakurai K, Fujii S. Impact of polyethylene glycol (PEG) conformations on the in vivo fate and drug release behavior of PEGylated core-cross-linked polymeric nanoparticles. Biomacromol. 2022;23(9):3909\u201318. https:\/\/doi.org\/10.1021\/acs.biomac.2c00730.","journal-title":"Biomacromol"},{"issue":"8","key":"3264_CR23","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-021-02115-6","volume":"22","author":"QA Ijaz","year":"2021","unstructured":"Ijaz QA, Latif S, Shoaib QU, Rashid M, Arshad MS, Hussain A, et al. Preparation and characterization of pH-independent sustained-release tablets containing hot melt extruded solid dispersions of Clarithromycin: tablets containing solid dispersions of Clarithromycin. AAPS PharmSciTech. 2021;22(8):275. https:\/\/doi.org\/10.1208\/s12249-021-02115-6.","journal-title":"AAPS PharmSciTech"},{"key":"3264_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212377","author":"EJ Go","year":"2021","unstructured":"Go EJ, Ryu BR, Ryu SJ, Kim HB, Lee HT, Kwon JW, et al. An enhanced water solubility and stability of anthocyanins in mulberry processed with hot melt extrusion. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222212377.","journal-title":"Int J Mol Sci"},{"key":"3264_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejpb.2023.07.020","volume":"190","author":"T Liu","year":"2023","unstructured":"Liu T, Zhang F. Modelling drug degradation of amorphous solid dispersion during twin-screw extrusion. Eur J Pharm Biopharm. 2023;190:197\u2013205. https:\/\/doi.org\/10.1016\/j.ejpb.2023.07.020.","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"3264_CR26","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1080\/03639045.2020.1821045","volume":"46","author":"H Wu","year":"2020","unstructured":"Wu H, Liu Y, Ci T, Ke X. Application of HPMC HME polymer as hot melt extrusion carrier in carbamazepine solid dispersion. Drug Dev Ind Pharm. 2020;46(12):1911\u20138. https:\/\/doi.org\/10.1080\/03639045.2020.1821045.","journal-title":"Drug Dev Ind Pharm"},{"key":"3264_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/polym12092111","author":"J Galvez","year":"2020","unstructured":"Galvez J, Correa Aguirre JP, Hidalgo Salazar MA, Vera Mondragon B, Wagner E, Caicedo C. Effect of extrusion screw speed and plasticizer proportions on the rheological, thermal, mechanical, morphological and superficial properties of PLA. Polymers. 2020. https:\/\/doi.org\/10.3390\/polym12092111.","journal-title":"Polymers"},{"issue":"6","key":"3264_CR28","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/1751-7915.14003","volume":"15","author":"B Ingham","year":"2022","unstructured":"Ingham B, Winterburn J. Developing an understanding of sophorolipid synthesis through application of a central composite design model. Microb Biotechnol. 2022;15(6):1744\u201361. https:\/\/doi.org\/10.1111\/1751-7915.14003.","journal-title":"Microb Biotechnol"},{"key":"3264_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26185432","author":"H Hassan","year":"2021","unstructured":"Hassan H, Adam SK, Alias E, Meor Mohd Affandi MMR, Shamsuddin AF, Basir R. Central composite design for formulation and optimization of solid lipid nanoparticles to enhance oral bioavailability of Acyclovir. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26185432.","journal-title":"Molecules"},{"issue":"1","key":"3264_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/03639045.2020.1862170","volume":"47","author":"Q Ye","year":"2021","unstructured":"Ye Q, Li J, Li T, Ruan J, Wang H, Wang F, et al. Development and evaluation of puerarin-loaded controlled release nanostructured lipid carries by central composite design. Drug Dev Ind Pharm. 2021;47(1):113\u201325. https:\/\/doi.org\/10.1080\/03639045.2020.1862170.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"3264_CR31","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02495-3","volume":"24","author":"SK Thota","year":"2023","unstructured":"Thota SK, Dudhipala N, Katla V, Veerabrahma K. Cationic solid SMEDDS of Efavirenz for improved oral delivery: development by central composite design, in vitro and in vivo evaluation. AAPS PharmSciTech. 2023;24(1):38. https:\/\/doi.org\/10.1208\/s12249-022-02495-3.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3264_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4155\/tde-2020-0025","volume":"11","author":"S Singh","year":"2020","unstructured":"Singh S, Sharma N, Kaur G. Central composite designed solid dispersion for dissolution enhancement of fluvastatin sodium by kneading technique. Ther Deliv. 2020;11(5):313\u201328. https:\/\/doi.org\/10.4155\/tde-2020-0025.","journal-title":"Ther Deliv"},{"issue":"1","key":"3264_CR33","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02208-w","volume":"23","author":"F Zhang","year":"2022","unstructured":"Zhang F, Mao J, Tian G, Jiang H, Jin Q. Preparation and characterization of furosemide solid dispersion with enhanced solubility and bioavailability. AAPS PharmSciTech. 2022;23(1):65. https:\/\/doi.org\/10.1208\/s12249-022-02208-w.","journal-title":"AAPS PharmSciTech"},{"issue":"44","key":"3264_CR34","doi-asserted-by":"publisher","first-page":"39907","DOI":"10.1021\/acsomega.2c04021","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Li Y, Ao W, Xiao Y, Bai M, Li S. Preparation and characterization of aprepitant solid dispersion with HPMCAS-LF. ACS Omega. 2022;7(44):39907\u201312. https:\/\/doi.org\/10.1021\/acsomega.2c04021.","journal-title":"ACS Omega"},{"key":"3264_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112264","author":"A Akram","year":"2022","unstructured":"Akram A, Irfan M, Abualsunun WA, Bukhary DM. How to improve solubility and dissolution of Irbesartan by fabricating ternary solid dispersions: optimization and in-vitro characterization. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14112264.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3264_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15432","volume":"9","author":"MA Nupur","year":"2023","unstructured":"Nupur MA, Rahman MM, Akter K, Hanif KB, Sharna JF, Sarker MS, et al. Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice. Heliyon. 2023;9(5):e15432. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15432.","journal-title":"Heliyon"},{"issue":"4","key":"3264_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/10837450.2019.1709502","volume":"25","author":"X Shi","year":"2020","unstructured":"Shi X, Fan N, Zhang G, Sun J, He Z, Li J. Quercetin amorphous solid dispersions prepared by hot melt extrusion with enhanced solubility and intestinal absorption. Pharm Dev Technol. 2020;25(4):472\u201381. https:\/\/doi.org\/10.1080\/10837450.2019.1709502.","journal-title":"Pharm Dev Technol"},{"key":"3264_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106036","volume":"168","author":"X Jiang","year":"2022","unstructured":"Jiang X, Zhao Y, Guan Q, Xiao S, Dong W, Lian S, et al. Amorphous solid dispersions of cyclosporine A with improved bioavailability prepared via hot melt extrusion: formulation, physicochemical characterization, and in vivo evaluation. Eur J Pharm Sci. 2022;168:106036. https:\/\/doi.org\/10.1016\/j.ejps.2021.106036.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3264_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040492","volume":"15","author":"S Inam","year":"2022","unstructured":"Inam S, Irfan M, Lali NUA, Khalid Syed H, Asghar S, Khan IU, et al. Development and characterization of Eudragit((R)) EPO-based solid dispersion of rosuvastatin calcium to foresee the impact on solubility, dissolution and antihyperlipidemic activity. Pharmaceuticals (Basel). 2022;15(4):492. https:\/\/doi.org\/10.3390\/ph15040492.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3264_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ph14010073","author":"BR Giri","year":"2021","unstructured":"Giri BR, Kwon J, Vo AQ, Bhagurkar AM, Bandari S, Kim DW. Hot-melt extruded amorphous solid dispersion for solubility, stability, and bioavailability enhancement of Telmisartan. Pharmaceuticals (Basel). 2021. https:\/\/doi.org\/10.3390\/ph14010073.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"28","key":"3264_CR41","doi-asserted-by":"publisher","first-page":"25195","DOI":"10.1021\/acsomega.3c02280","volume":"8","author":"DR Telange","year":"2023","unstructured":"Telange DR, Bhaktani NM, Hemke AT, Pethe AM, Agrawal SS, Rarokar NR, et al. Development and characterization of pentaerythritol-EudragitRS100 co-processed excipients as solid dispersion carriers for enhanced aqueous solubility, in vitro dissolution, and ex vivo permeation of Atorvastatin. ACS Omega. 2023;8(28):25195\u2013208. https:\/\/doi.org\/10.1021\/acsomega.3c02280.","journal-title":"ACS Omega"},{"key":"3264_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111293","volume":"196","author":"G Yan","year":"2020","unstructured":"Yan G, Liang Q, Wen X, Peng J, Deng R, Lv L, et al. Preparation, characterization, and pharmacokinetics of tilmicosin taste-masked formulation via hot-melt extrusion technology. Colloids Surf B Biointerfaces. 2020;196:111293. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111293.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"3264_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4274\/tjps.galenos.2018.04880","volume":"17","author":"SB Sapkal","year":"2020","unstructured":"Sapkal SB, Adhao VS, Thenge RR, Darakhe RA, Shinde SA, Shrikhande VN. Formulation and characterization of solid dispersions of Etoricoxib using natural polymers. Turk J Pharm Sci. 2020;17(1):7\u201319. https:\/\/doi.org\/10.4274\/tjps.galenos.2018.04880.","journal-title":"Turk J Pharm Sci"},{"issue":"1","key":"3264_CR44","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1080\/10717544.2022.2083723","volume":"29","author":"DA Gaber","year":"2022","unstructured":"Gaber DA, Alnwiser MA, Alotaibi NL, Almutairi RA, Alsaeed SS, Abdoun SA, et al. Design and optimization of ganciclovir solid dispersion for improving its bioavailability. Drug Deliv. 2022;29(1):1836\u201347. https:\/\/doi.org\/10.1080\/10717544.2022.2083723.","journal-title":"Drug Deliv"},{"key":"3264_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112450","author":"S Dharani","year":"2022","unstructured":"Dharani S, Mohamed EM, Khuroo T, Rahman Z, Khan MA. Formulation characterization and pharmacokinetic evaluation of amorphous solid dispersions of Dasatinib. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14112450.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3264_CR46","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/fsn3.3900","volume":"12","author":"R Mukai","year":"2024","unstructured":"Mukai R, Hata N. Tissue distribution and pharmacokinetics of isoxanthohumol from hops in rodents. Food Sci Nutr. 2024;12(3):2210\u20139. https:\/\/doi.org\/10.1002\/fsn3.3900.","journal-title":"Food Sci Nutr"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03264-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:05:50Z","timestamp":1770314750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03264-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3264"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03264-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study involving rats was approved by the animal ethical committee of the Inner Mongolia Medical University in China (YKD202302091).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Text. e.g. All participants provided written informed consent before recruitment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Inform Consent"}},{"value":"All authors declare that they have no competing interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"7"}}